Surmodics (NASDAQ:SRDX) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.11) by 18.18 percent. This is a 285.71 percent decrease over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $28.09 million which missed the analyst consensus estimate of $32.23 million by 12.86 percent. This is a 12.12 percent decrease over sales of $31.96 million the same period last year.